QIAGEN Wins Industry Excellence Award for "Best Licensing Deal of the Year" in Animal Health
Sep 26 2007

QIAGEN Wins Industry Excellence Award for "Best Licensing Deal of the Year" in Animal Health

Jury recognized strategic value of partnership with VLA to commercialize molecular tests for infectious veterinary diseases

Venlo, The Netherlands, September 26, 2007. QIAGEN, the world's leading provider of sample and assay technologies for life sciences, applied testing and molecular diagnostics, has received the prestigious Animal Pharm Industry Excellence Award 2007 for the "Best Licensing Deal of the Year" in the animal health industry. The award, which was announced at the Animal Pharm Awards ceremony on September 25 in London, is bestowed annually to individuals and organizations who demonstrated remarkable achievements in veterinary health.

The jury, consisting of 12 independent industry experts, recognized the strategic value of the licensing agreement which QIAGEN entered with the British Veterinary Laboratories Agency (VLA) in October 2006. This collaboration allowed QIAGEN to enter the fast growing market for veterinary tests with validated assays, and to provide veterinary diagnostic laboratories around the world with faster, more sensitive, next generation PCR-based veterinary diagnostic technologies. As part of this agreement, QIAGEN acquired rights to commercialize a portfolio of PCR-based, molecular tests for infectious veterinary diseases affecting livestock such as horses and cattle. These diagnostic tests were developed and validated by the VLA and based on QIAGEN's sample and assay technologies.

"This partnership brings together one of the world's largest veterinary research and diagnostic testing facilities with the market leader in sample and assay technologies," said Simone Gauch, QIAGEN's Director Global Marketing Applied Testing. "This relationship combines QIAGEN's strong technological capabilities with VLA's in-depth expertise in animal diseases and veterinary diagnostics. The assay portfolio resulting from this collaboration has the potential to increase QIAGENfs strong competitive advantage in the market place."

"QIAGEN has a strong presence in the veterinary research and testing market," said Dr. Andrew Soldan, Commercial Programme Manager for VLA. "This partnership is a great example of collaborations between the public and private sectors that will further enhance the VLA reputation and facilitate the application of PCR technologies to a larger number of veterinary laboratories. The royalty-based agreement will give VLA the opportunity to fund future research and benefit QIAGEN by providing access to a significant portfolio of validated assays."

About QIAGEN

QIAGEN N.V., a Netherlands holding company is the leading provider of innovative sample and assay technologies and products. QIAGENfs products are considered standards in areas such pre-analytical sample preparation and assay solutions in research for life sciences, applied testing and molecular diagnostics. QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, nucleic acid and protein handling, separation, and purification and open and target specific assays. The company's products are sold to academic research markets, to leading pharmaceutical and biotechnology companies, to applied testing customers (such as in forensics, veterinary, biodefense and industrial applications) as well as to molecular diagnostics laboratories. QIAGEN employs more than 2,600 people worldwide. QIAGEN products are sold through a dedicated sales force and a global network of distributors in more than 40 countries.

 

About VLA

The Veterinary Laboratories Agency (VLA) is an Executive Agency of the Department for Environment Food and Rural Affairs (Defra) and is a regional network of 16 laboratories. The Agency is one of the largest research and diagnostic testing facilities of its kind in the world. Its aim is to safeguard public and animal health through world class research and surveillance of farmed livestock. VLA is one of the worldfs most renowned reference laboratories for a wide range for diseases in farm animals. More information on VLA can be found at http://www.vla.gov.uk/.

About Animal Pharm and the Animal Pharm Industry Excellence Awards

Animal Pharm is the leading source of news, business and technology information on the global veterinary industry and a part of Informa Healthcare, the leading provider of business information for the pharmaceutical, biotechnology, medical devices, diagnostics, instrumentation, crop protection, animal health and brewing industries.

In 2006, Animal Pharm launched the first Animal Pharm Industry Excellence Awards as a platform designed to recognise and celebrate remarkable achievements of individuals and organisations working in the animal health industry. More information can be found at http://www.animalpharmawards.com/.

Register here to be first to receive the latest launch information.

###

Contact

Dr. Thomas Theuringer
Associate Manager Public Relations
QIAGEN GmbH
Tel: + 49 (0) 2103-29-11826
email: thomas.theuringer@qiagen.com

Simone Gauch
Director Global Marketing Applied Testing
QIAGEN GmbH
Tel.: + 49 (0) 2103-29-16348
Email: simone.gauch@qiagen.com

FOLLOW US ON SOCIAL MEDIA

Share this page